Vir Biotechnology, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Vir Biotechnology, Inc. | VIR - NASDAQ |
$20.00-$22.00 | $20.00 | $16.15 | 7.1 million | 10/11/2019 |
| Goldman Sachs, JP Morgan, Cowen, Barclays | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2019-09-03 Terms Added 2019-09-30 | ||||||
Vir Biotechnology, Inc. Quote & Chart - Click for current quote - VIR
IPO Boutique aggregates information on public companies and private companies, such as "VIR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Vir Biotechnology, Inc. (adapted from Vir Biotechnology, Inc. prospectus):
They are a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "VIR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.